Article

Nontuberculous Mycobacteria in Respiratory Tract Infections, Eastern Asia

Department of Pulmonary Diseases, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.
Emerging Infectious Diseases (Impact Factor: 7.33). 03/2011; 17(3):343-9. DOI: 10.3201/eid1703.100604
Source: PubMed

ABSTRACT To characterize the distribution of nontuberculous mycobacteria (NTM) species isolated from pulmonary samples from persons in Asia and their association with pulmonary infections, we reviewed the literature. Mycobacterium avium complex bacteria were most frequently isolated (13%-81%) and were the most common cause of pulmonary NTM disease (43%-81%). Also pathogenic were rapidly growing mycobacteria (M. chelonae, M. fortuitum, M. abscessus). Among all NTM isolated from pulmonary samples, 31% (582/1,744) were considered clinically relevant according to American Thoracic Society diagnostic criteria. Most patients were male (79%) and had a history of tuberculosis (37%). In Asia, high prevalence of rapidly growing mycobacteria and a history of tuberculosis are distinct characteristics of pulmonary NTM disease. This geographic variation is not well reflected in the American Thoracic Society criteria for NTM infections and could be incorporated in future guidelines.

Download full-text

Full-text

Available from: Jakko van Ingen, Jul 07, 2015
0 Followers
 · 
162 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: AimsThe purpose of this study was to evaluate the usefulness of REBA Myco-ID® assay based on the principle of reverse blot hybridization assay (REBA) for the rapid detection of Mycobacterium tuberculosis (MTB), the differentiation of MTB from nontuberculous mycobacteria (NTM), and the identification of NTM species in liquid cultures.Methods and ResultsA total of 274 mycobacteiral liquid cultures that cultured from respiratory specimens including 94 AFB smear-positives and 180 AFB smear-negatives were used in this study. The results of PCR-REBA were compared with those of real-time PCR and PCR-RFLP assays. Sensitivity of 195 MTB and 79 NTM strains was determined using DNA isolated from liquid cultures was 100% and 97.5%, respectively. However, two of the liquid culture NTM specimens were not detected by PCR-REBA, and were identified as Rhodococcus jostii and R. erythropolis by PRA Myco-ID and rpoB sequence analysis. Frequently identified NTM species in the liquid cultures were M. avium complex (n = 50, 63.3%) and M. abscessus complex (n =11, 13.9%). The PCR-REBA is able to identify mycobacteiral strains more rapidly than conventional tests, and does not require specialized instruments and is possible to differentiate between M. abscessus and M. massiliense strains.ConclusionsPCR-REBA assay showed rapid, highly sensitive, and specific results for the identification of MTB and NTM, and discriminated between NTM species from mycobacterial liquid cultures.Significance and Impact of the StudyEven though the use of molecular diagnostic technologies is more expensive than the use of conventional methods, the clinical and economic benefit of saving time in regard to expenses remains to be elucidated. Therefore, the PCR-REBA assay may provide the essential information to accelerate therapeutic decisions for appropriate antibiotic treatments in the acute phase of mycobacterial diseases.This article is protected by copyright. All rights reserved.
    Journal of Applied Microbiology 10/2014; DOI:10.1111/jam.12670 · 2.39 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The incidence of nontuberculous mycobacteria (NTM) has increased over the last decades. Elderly people are more susceptible to NTM and experience increased morbidities. NTM incidence is expected to rise due to an increasing elderly population at least up to 2050. Given the importance of NTM infection in the elderly, an increasing interest exists in studying NTM characteristics in the aged population. In this review, we summarize the characteristics of NTM infection among elderly patients. We focus on epidemiology, clinical presentation, and treatment options of NTM in this age group. We highlight the differences in the diagnosis and treatment between rapid and slow growing mycobacterial infections. The current recommendation for treatment of NTM is discussed. We debate if in vitro susceptibility testing has a role in the treatment of NTM. Drug-drug interaction between antibiotics used to treat NTM and other medications, particularly warfarin, is another important issue that we discuss. Finally, we review the prognosis of NTM disease in elderly patients.
    European Journal of Internal Medicine 03/2014; 25(4). DOI:10.1016/j.ejim.2014.03.008 · 2.30 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The genus Mycobacterium consists of over 120 known species, some of which (e.g. M. bovis and M. tuberculosis) contribute extensively to the burden of infectious disease in humans and animals, whilst others are commonly found in the environment but may rarely if ever be disease-causing. This paper reviews the mycobacteria found in southern Africa, focussing on those in the M. tuberculosis complex as well as the non-tuberculous mycobacteria (NTM), identifying those found in the area and including those causing disease in humans and animals, and outlines some recent reports describing the distribution and prevalence of the disease in Africa. Difficulties in diagnosis, host preference and reaction, immunology and transmission are discussed.
    Transboundary and Emerging Diseases 11/2013; 60(s1). DOI:10.1111/tbed.12159 · 3.12 Impact Factor